Back to search results

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI

Abroad (travel likely)Recruiting

Conditions

Ischemic Cardiovascular Disease · Multivessel Coronary Artery Disease · Coronary Artery Disease · Cardiogenic Shock · Acute Heart Failure (AHF) · Chronic Heart Failure · Percutaneous Coronary Intervention

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • NMRCCardiologyRu, Moscow, Russia

    Contact: Study coordinator (Lavrentii Dulaev) · la.dulaev@mail.ru · 4240030
    Contact: Study coordinator (Nikita Grishin) · n.s.grishin@mail.ru · 5799185
    Andrey Tereshchenko, PhD (Sub-investigator)
    Contact: Principal Investigator (Goar Arutiunian, PhD)
    Ilia Zyuryaev (Sub-investigator)
    Irina Merkulova (Sub-investigator)
    Tatiana Sukhinina, PhD (Sub-investigator)
    Ivan Zharovin (Sub-investigator)
    Elizaveta Krasnoperova (Sub-investigator)
    Pavel Kushnir (Sub-investigator)
Study leads

  • Dmitry Pevzner, MD

    Principal Investigator

    National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

  • Evgeniy Merkulov, MD

    Principal Investigator

    National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

View source on ClinicalTrials.gov(opens in a new tab)